arginine has been researched along with Breast Cancer in 173 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (8.09) | 18.7374 |
1990's | 24 (13.87) | 18.2507 |
2000's | 54 (31.21) | 29.6817 |
2010's | 52 (30.06) | 24.3611 |
2020's | 29 (16.76) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fu, D; Huang, X; Lv, Z; Su, D; Zhang, W; Zhang, Y | 1 |
Chen, W; Hou, R; Li, Q; Liang, H; Yang, Y; Zhang, Y | 1 |
Hou, Y; Liu, X; Su, R; Xu, J; Yang, T; Zhao, M | 1 |
Zaki Mahdi, N | 1 |
Feng, X; Gu, J; Han, W; Hu, X; Huang, J; Ji, Z; Lei, L; Li, F; Li, L; Li, N; Ren, W; Sun, C; Wang, T; Wu, Z | 1 |
Abdelraof, M; Allam, RM; Hassabo, AA | 1 |
Avtandilyan, N; Bartoszek, A; Ginovyan, M; Jakubek, P; Javrushyan, H; Karapetyan, A; Koss-Mikołajczyk, I; Koziara, Z; Kuczyńska, M; Kusznierewicz, B; Maloyan, A; Petrosyan, G; Sahakyan, N | 1 |
Fields, L; Kim, EJ; Li, L; Liu, F; Ma, M; Miles, HN; Xu, W | 1 |
Deng, G; Hussain, A; Kang, X; Xie, L | 1 |
Chen, Q; Chen, Y; Hu, Q; Li, A; Li, J; Li, L; Shen, N; Zhang, N | 1 |
Bernhardt, G; Keller, M; Kuwert, T; Maschauer, S; Ott, JJ; Prante, O | 1 |
Avtandilyan, N; Grigoryan, A; Javrushyan, H; Mamikonyan, A; Trchounian, A | 1 |
Bäcker, S; Bier, D; Gago, F; Gigante, A; Hu, X; Knauer, S; Ottmann, C; Sánchez-Murcia, PA; Schmuck, C; Sijbesma, E | 1 |
Hakimelahi, A; Kassaee, SM; Mahmoodi, M; Sharifi, R | 1 |
Duan, D; Feng, J; Huang, B; Ji, J; Li, L; Li, Z; Lin, C; Lin, L; Liu, J; Liu, L; Lu, J; Zhang, N; Zhang, Y | 1 |
Gao, J; Guo, B; Hu, C; Long, H; Shu, C; Wang, X; Yang, F; Zha, H; Zhou, L; Zhu, B | 1 |
Hwang, JW; Hwang, KT; Jang, CY; Kim, NH; Kim, S; Kim, YA; Kim, YK; Myung, N; Park, JE | 1 |
Beato, M; Sharma, P | 1 |
Fernando, V; Furuta, S; Letson, J; Sharma, V; Walia, Y; Zheng, X | 1 |
David, Y; Osunsade, A; Zheng, Q | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Huang, B; Li, H; Li, L; Liu, DX; Liu, J; Liu, L; Liu, X; Liu, Y; Lu, J; Peng, L; Wang, G; Wang, Y; Zhang, L; Zhang, Y | 1 |
Anderson, JN; Bao, Y; Bartlett, JR; Bissonnette, S; Briant, AR; Carcel, C; Chan, K; Chen, H; Chen, L; Cheng, C; Chrétien, M; Conway Fitzgerald, A; Cyr, Y; Du, Y; El-Sayed, YY; Endo, T; Faraj, M; Fujimoto, K; Girsen, A; Goto, H; Hashimoto, D; Hayasaka, K; Hayase, E; Herrmann, N; Hidaka, D; Holst, JJ; Igbinosa, I; Iijima, H; Jeandidier, N; Jeong, DY; Jeong, GT; Joubert, M; Kagawa, I; Kahata, K; Kaushik, LK; Kim, SK; Kim, SR; Kuang, Y; Laird, M; Lamantia, V; Li, P; Li, Y; Li, Z; Lindsay, SE; Liu, X; Loizon, E; Lu, Z; Lyell, DJ; Ma, J; Magnani, CJ; Mahalingam, AK; Mandal, N; Mayer, G; Michimata, R; Ngo Sock, ET; Okada, K; Onozawa, M; Opigez, V; Palanisamy, M; Parienti, JJ; Park, YR; Pavlikova, B; Peyro Saint Paul, L; Ramsahye, N; Reyes, GA; Reznik, Y; Richardson, MT; Samo, IA; Sarkar, R; Shendge, AK; Shimizu, C; Shiratori, S; Steinberg, JR; Sugita, J; Sukwong, P; Sun, X; Sunagoya, K; Sunwoo, IY; Svendsen, B; Tang, L; Tang, Z; Teshima, T; Totée, C; Turner, BE; Unno, M; Vidal, H; Wang, C; Wang, M; Wang, S; Wang, X; Wang, Z; Wassef, H; Weeks, BT; Wong Chi Man, M; Xu, C; Xu, W; Yamamoto, S; Yu, H; Zhang, WY; Zhang, X; Zhong, Y | 1 |
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Arshad, A; Charles, S; Madhavan, T; Mala, K; Munusamy-Ramanujam, G; Saraswathi, NT; Singh, P | 1 |
Da Costa, RSS; Esteves, VF; Koifman, RJ; Koifman, S; Schilling, MPR; Silva, IFD | 1 |
Bel'skaya, LV; Kosenok, VK; Sarf, EA | 1 |
Chen, L; da Silva, SR; Gao, SJ; Ju, E; Li, T; Wang, X; Wei, S; Zhang, X | 1 |
Gao, X; He, YH; Hu, GS; Huang, HH; Huang, MF; Li, WJ; Lin, YA; Liu, W; Peng, BL; Ran, T; Xie, BL; Yang, JJ; Ye, F; Zhu, HH | 1 |
Cao, D; Ding, H; Hou, J; Huang, B; Lin, C; Liu, J; Liu, L; Liu, X; Liu, Y; Lu, J; Wang, G; Zhang, N; Zhang, X; Zhang, Y | 1 |
Irfandi, R; Prihantono, P; Raya, I | 1 |
Ball, LE; Brobbey, C; Gan, W; Liu, L; Olsen, SK; Ostrowski, MC; Palanisamy, V; Yin, S | 1 |
Fan, B; Gao, Z; Huang, W; Jin, H; Jin, M; Kang, L; Sun, P; Wang, QM | 1 |
Coon, JJ; Hebert, AS; Kwiecien, NW; Liu, F; Shishkova, E; Xu, W; Zeng, H | 1 |
Lenihan, DJ | 1 |
Bradbury, A; Carver, JR; Clark, A; DeMichele, A; Domchek, S; Finkelman, BS; Fox, K; Ky, B; Matro, J; Narayan, H; Narayan, V; Putt, M; Shah, P; Tang, WHW; Wang, L; Wang, T | 1 |
Allasia, A; Deutz, NEP; Engelen, MPKJ; Klimberg, VS | 1 |
Barber, DL; Hernandez, RD; Jacobson, MP; Ruiz, DG; Strauli, NB; Szpiech, ZA; White, KA | 1 |
Fogel, J; Obiagwu, C; Verma, S | 1 |
Anastasiou, M; Antonopoulos, AS; Bamias, A; Dimopoulos, MA; Oikonomou, E; Psaltopoulou, T; Siasos, G; Tousoulis, D; Zagouri, F | 1 |
Finkelman, BS; Ky, B; Putt, M | 1 |
Chen, H; Liu, YB; Ngernyuang, N; Oh, D; Schwartz, LM; Shao, R; Yan, W | 1 |
Che, Y; Duan, X; Gao, H; Guo, W; Huang, J; Huang, T; Jin, Y; Lei, L; Li, Y; Ma, H; Ren, W; Xia, X; Zhai, T | 1 |
Barlow, D; Frazier, K; Greenstein, I; Harding, L; Mohan, S; Ng, C; Nguyen, G; Patel, S | 1 |
Azadbakht, M; Jahani, M; Mansouri, K; Rasouli, H; Rezazadeh, D; Salari, N; Yarani, R | 1 |
Beato, M; Carbonell-Caballero, J; Di Vona, C; Eick, D; Fernandez-Fuentes, N; Le Dily, F; Lioutas, A; Oliva, B; Quilez, J; Schüller, R; Sharma, P; Wright, RHG | 1 |
Chlopicki, S; Jasztal, A; Kij, A; Kus, K; Stojak, M; Walczak, M; Zakrzewska, A | 1 |
Dowhan, DH; Muscat, GEO; Wang, SM | 1 |
Labhasetwar, V; Lu, S; Morris, VB | 1 |
Cheng, MB; Fan, XZ; Liu, LM; Sun, WZ; Xu, YL; Zhang, Y | 1 |
Bala, A; Panditharadyula, SS | 1 |
Cortez, V; Mann, M; Vadlamudi, R | 1 |
Ferrari, M; Gu, J; Guo, X; Kim, HC; Liu, X; Mai, J; Mao, ZW; Mu, C; Qin, G; Shen, H; Shen, J; Wolfram, J; Xia, X; Xu, R; Yang, Y | 1 |
Avliyakulov, NK; Braga, M; Chaudhuri, G; Haykinson, MJ; Martinez, L; Parveen, M; Pervin, S; Singh, R; Singh, V | 1 |
Corbo, L; Hussein, N; Le Romancer, M; Poulard, C; Rambaud, J | 1 |
Ann, DK; Chen, YR; Chu, CY; Forman, HJ; Gaur, S; Huang, J; Kung, HJ; Liu, X; Qiu, F; Shen, LJ; Xu, J; Yen, Y; Zhang, H; Zheng, S | 1 |
Chung, HH; Lin, VC; Sun, Y; Woo, AR | 1 |
Geng, D; Sun, D; Zhang, L; Zhang, W | 1 |
Chen, WC; Cho, CY; Hsu, HP; Huang, HL; Hung, YH; Lai, MD; Wang, CY | 1 |
Bahar, I; Fujita, N; Gamper, A; Gur, M; Hu, D; Hung, MC; Lan, L; Wan, Y; Zhou, Z | 1 |
Jheng, PR; Lu, KY; Mi, FL; Yu, SH | 1 |
Geck, RC; Toker, A | 1 |
Aldashev, AA; Asambaeva, DA; Isakova, ZhT; Makieva, KB; Sultangazieva, BB | 1 |
Cao, XL; Gao, JX; Li, LF; Liu, N; Liu, SS; Sun, L; Xia, WY; Xiu, P; Zhao, SH | 1 |
Chen, H; Gupta, V; Lorton, B; Shechter, D | 1 |
Harding, L; Mohan, S; Moua, N | 1 |
Alshetaiwi, H; Bossmann, SH; Malalasekera, AP; McLaurin, EJ; Ortega, R; Samarakoon, TN; Shrestha, TB; Troyer, DL; Udukala, DN; Wang, H; Yapa, AS | 1 |
Cao, Y; Gao, Y; Guo, S; Hu, L; Hu, X; Jing, F; Jing, Y; Wang, Y; Xu, M; Zhang, Y; Zhu, Z | 2 |
Azadbakht, M; Jahani, M; Mansouri, K; Norooznezhad, F | 1 |
Abdelmagid, SA; Too, CK | 1 |
Amadori, D; Bonafe, M; Brigliadori, G; Fabbri, F; Gusolfino, D; Massa, I; Passardi, A; Ricci, M; Rosetti, M; Sansone, P; Storci, G; Tesei, A; Ulivi, P; Vannini, I; Zoli, W | 1 |
Bouchekioua-Bouzaghou, K; Corbo, L; Gobert-Gosse, S; Goddard, S; Le Romancer, M; Leconte, N; Robin-Lespinasse, Y; Sentis, S; Treilleux, I | 1 |
Bucholtz, KM; Kacsoh, B; Mack, VL; Sun, J; Thomas, JL | 1 |
Anyanwu, SN; Bunker, CH; Ezeome, ER; Ferrell, RE; Garte, SJ; Kuller, LH; Okobia, MN; Taioli, E; Uche, EE; Zmuda, JM | 1 |
Graczyk, A; Kasprzycka-Guttman, T; Misiewicz-Krzemińska, I; Skupińska, K | 1 |
Bizarro, S; Castro, F; Cerveira, N; Henrique, R; Peixoto, A; Pereira, D; Pinheiro, M; Rocha, P; Rodrigues, H; Santos, C; Soares, MJ; Teixeira, MR; Vega, A | 1 |
Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
Chang, Y; Liang, D; Liu, Z; Qi, R; Song, T; Sun, X; Vogel, U; Yin, J; Yue, L | 1 |
Andò, S; Barone, I; Beyer, A; Corona-Rodriguez, A; Cui, Y; Fuqua, SA; Giordano, C; Herynk, MH; Selever, J | 1 |
Rieber, M; Strasberg Rieber, M | 1 |
Belyavskaya, VA; Cherdyntseva, NV; Denisov, EV; Litvyakov, NV; Malinovskaya, EA; Slonimskaya, EM; Stegniy, VN; Voevoda, MI | 1 |
Chakosari, RJ; Kazemi, M; Salehi, Z | 1 |
Cavaillès, V; Corbo, L; Jalaguier, S; Le Romancer, M; Sentis, S; Teyssier, C | 1 |
Benner, A; Burwinkel, B; Hahn, M; Lichter, P; Marmé, F; Schneeweiss, A; Sinn, P; Sohn, C; Werft, W | 1 |
Casimiro, MC; Chiavarina, B; Flomenberg, N; Frank, PG; Howell, A; Lisanti, MP; Martinez-Outschoorn, UE; Migneco, G; Pavlides, S; Pestell, RG; Sotgia, F; Tsirigos, A; Wang, C; Whitaker-Menezes, D | 1 |
Abdelmagid, SA; McDonald, WJ; Rickard, JA; Thomas, LN; Too, CK | 1 |
Haramoto, M; Horibe, T; Kawakami, K; Kohno, M; Ohara, K; Tada, N | 1 |
Aloj, SM; Chiaviello, A; Paciello, I; Palumbo, G; Veneziani, BM | 1 |
Padma, T; Raghunadharao, D; Rao, DN; Sailaja, K; Surekha, D; Vishnupriya, S | 1 |
Akita, N; Asanuma, K; Asanuma, Y; Hayashi, T; Matsumine, A; Okamoto, T; Sudo, A; Uchida, A; Wakabayashi, H; Yoshikawa, T | 1 |
Kim, PH; Kim, SW; Nam, HY; Nam, K | 1 |
Bernhardt, G; Buschauer, A; Keller, M; Lopuch, M; Memminger, M; Pop, N; von Angerer, E | 1 |
Chaudhuri, G; Pervin, S; Singh, R | 2 |
Andersen, TI; Bregård, A; Bukholm, IR; Børresen-Dale, AL; Langerød, A; Lothe, RA; Lønning, PE; Meling, GI; Rognum, TO | 1 |
Barbi, C; Bonafé, M; Ceccarelli, C; Farabegoli, F; Franceschi, C; Marzi, E; Olivieri, F; Santini, D; Storci, G; Taffurelli, M; Trapassi, C | 1 |
Hamajima, N; Hirose, K; Huang, XE; Iwata, H; Katsuda, N; Matsuo, K; Miura, S; Mizutani, M; Tajima, K; Tokudome, S; Xiang, J | 1 |
Radisavljevic, Z | 1 |
Alqawi, O; Bates, S; Georges, E | 1 |
Caso, G; Eremin, O; Garlick, PJ; McMillan, ND; McNurlan, MA | 1 |
Miyoshi, Y; Noguchi, S; Noma, C; Taguchi, T; Tamaki, Y | 1 |
Balakrishnan, L; Janvilisri, T; Shahi, S; van Veen, HW; Venter, H | 1 |
De León, DD; Faridi, JS; Mohan, S | 1 |
Cao, C; Kufe, D; Leng, Y; Li, P; Li, Y; Ma, Q | 1 |
Dejong, CH; Deutz, NE; Fearon, KC; Luiking, YC; Vissers, YL; von Meyenfeldt, MF | 1 |
Finley, RL; Li, X; Meng, Y; Reddy, N; Sakr, W; Sheng, S; Yang, H; Yin, S | 1 |
Bange, J; Knyazev, P; Stadler, CR; Ullrich, A | 1 |
Gao, J; Hu, Z; Jin, G; Liu, J; Qing, J; Shen, H; Wang, S; Wang, X; Zhai, X | 1 |
Ambrosone, CB; Chang-Claude, J; Haase, W; Helmbold, I; Kropp, S; Popanda, O; Sautter-Bihl, ML; Schmezer, P; Tan, XL; von Fournier, D; Wenz, F | 1 |
Azuma, H; Ehata, S; Horie, S; Imamura, T; Inamoto, T; Itoh, Y; Katsuoka, Y; Kiyama, S; Kiyama, Y; Maruyama, O; Miyazaki, H; Miyazono, K; Otsuki, Y; Sakamoto, T; Takahara, S; Ubai, T; Watabe, T | 1 |
Beloussow, K; Shen, LJ; Shen, WC | 1 |
Bange, J; Harbeck, N; Hoefler, H; Kates, R; Kiechle, M; Kriner, M; Nahrig, J; Streit, S; Thussbas, C; Ullrich, A; Ulm, K | 1 |
Hoffman, RM; Li, S; Li, X; Ma, H; Tan, X; Yang, M; Yang, Z; Zhao, M | 1 |
Bergamaschi, D; Bisso, A; Breyssens, H; Crook, T; Del Sal, G; Gasco, M; Lu, X; Samuels, Y; Smith, P; Sullivan, A; Syed, N; Zvelebil, M | 1 |
Alexandre, CO; Damin, AP; Damin, DC; Frazzon, AP; Hermes, V; Roehe, A; Zettler, C | 1 |
Corbo, L; Kolytcheff, C; Le Romancer, M; Robin-Lespinasse, Y; Rostan, MC; Sentis, S | 1 |
Bonafé, M; Chieco, P; Montanaro, L; Pandolfi, S; Sansone, P; Storci, G | 1 |
Kim, DH; Kim, JH; Kim, KW; Min, BH; Yu, YS | 1 |
Arnold, S; Brown, MA; Buchanan, D; Chenevix-Trench, G; Couch, FJ; Farrugia, DJ; Goldgar, DE; Healey, S; Henderson, BR; Lakhani, SR; Lovelock, PK; Mok, MT; Spurdle, AB; Tavtigian, SV | 1 |
Al-Katib, W; Allan, AL; Chambers, AF; Goodale, D; Hedley, BD; Postenka, CO; Schulze, EB; Tuck, AB | 1 |
Berghoffer, B; Bodwin, JS; Cho-Chung, YS; Clair, T | 1 |
Groom, GV; Paterson, AG; Turkes, A; Webster, DJ | 1 |
Bani, D; Bello, MG; Bigazzi, M; Masini, E; Sacchi, TB | 1 |
Aberle, H; Bierkamp, C; Heidkämper, C; Lynch, HT; Montagna, M; Natt, E; Serova, O; Torchard, D; Wagner, T; Wirsching, J | 1 |
Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, J | 1 |
Ah-See, AK; Brittenden, J; Eremin, O; Gilbert, F; Heys, SD; Hutcheon, AW; McKean, M; Miller, I; Needham, G; Sarkar, TK | 1 |
Abbondanza, C; Armetta, I; Medici, N; Molinari, AM; Moncharmont, B; Napolitano, M; Nigro, V; Puca, AA; Puca, GA; Schiavulli, M | 1 |
Ah-See, Ak; Ashby, J; Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, C | 1 |
Balbín, M; Ferrando, AA; Fueyo, A; Hannon, GJ; López-Otín, C; Pendás, AM; Vizoso, F | 1 |
Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG | 1 |
Alalami, O; Martin, JH | 1 |
Eckelman, WC; John, C; Lang, L; Leyton, J; Moody, TW; Unsworth, E | 1 |
Børresen-Dale, AL; Helland, A; Johnsen, H; Langerød, A; Olsen, AO; Skovlund, E | 1 |
Bansal, RK; Dai, JL; Kern, SE | 1 |
Alfarano, A; Becchis, M; Biglia, N; Coluccia, C; Fazzari, A; Ferrera, P; Fortunati, N; Frairia, R; Ondei, S; Sismondi, P | 1 |
Cederbaum, S; Chaudhuri, G; Karimi, A; Pervin, S; Singh, R | 1 |
Dokianakis, DN; Papadakis, EN; Spandidos, DA | 1 |
Chen, WY; Ramamoorthy, P; Sticca, R; Wagner, TE | 1 |
Bell, DW; Garber, JE; Gray, H; Haber, DA; Iglehart, DJ; Kaelin, CM; Lunetta, KL; Marks, JR; Nasser, SM; Polyak, K; Rhei, E; Seth, P | 1 |
Chang, CI; Kuo, L; Liao, JC | 1 |
Pham, HT; Ruediger, R; Walter, G | 1 |
Blagosklonny, MV; Fojo, T; Giannakakou, P; Romanova, LY; Ryan, KM; Vousden, KH | 1 |
Chaudhuri, G; Pervin, S; Singh, R; Wu, G | 1 |
Bange, J; Cheburkin, Y; Gärtner, S; Harbeck, N; Häring, HU; Höfler, H; Iacobelli, S; Imyanitov, E; Knayzev, P; Knyazeva, T; Müller, S; Prechtl, D; Schmitt, M; Specht, K; Sures, I; Ullrich, A; Wang, H | 1 |
Alksne, JF; Lachelin, GC; Yen, SC | 1 |
Blessing, K; Eremin, O; Garlick, PJ; Heys, SD; Kelly, P; McNurlan, MA; Park, KG | 1 |
Beaupain, R; Coulomb, B; Galle, P; Hindie, E | 1 |
Hitch, DC; Kubota, A; Meguid, MM | 1 |
Cattran, DC; Chow, S; Roscoe, J | 1 |
Lindall, AW; Novelli, E; Theologides, A | 1 |
Cui, J; Jiang, S; Li, Y; Liu, Z; Ma, L; Wang, Y; Yin, Q; Yu, H; Zhang, Z | 1 |
Chu, B; Hu, L; Li, X; Lin, G; Shi, L; Shi, S; Xu, Q; Ye, L; Zhang, H; Zhang, N; Zhang, X | 1 |
Di, X; Dumur, C; Elmore, LW; Gewirtz, DA; Holt, SE | 1 |
Schwarz, MA; Snyder, RD | 1 |
Calciati, A; Conte, PF; Giaccone, G; Musella, R | 1 |
Asselain, B; Bretaudeau, B; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P | 1 |
Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Talamini, R; Tirelli, U; Trovó, MG; Tumolo, S; Veronesi, A | 1 |
Carbone, A; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Veronesi, A; Volpe, R | 1 |
Schulz, JJ; Speckhart, VJ; Spremulli, E; Wampler, GL | 1 |
Fornari, FA; Gewirtz, DA; Orr, MS; Randolph, JK | 1 |
Cowan, KH; Horton, JK; Nakagawa, M; Schneider, E; Yang, CH | 1 |
Bunch, RT; Fornari, FA; Gewirtz, DA; Orr, MS; Povirk, LF; Randolph, JK; Ritke, MK; Yalowich, JC | 1 |
Beijnen, JH; Boogerd, W; Nooijen, WJ; van Tellingen, O | 1 |
Gewirtz, DA; Jain, PT; Orr, MS; Randolph, JK; Sundaram, S; Watson, NC | 1 |
Bianco, C; Ciardiello, F; Damiano, V; Davies, SL; di Isernia, G; Harris, AL; Hickson, ID; North, P; Pepe, S; Tortora, G | 1 |
Khodjakov, A; Sánchez-Alcázar, JA; Schneider, E | 1 |
Cleveland, JL; Di, YM; Gewirtz, DA; Jain, PT; Magnet, KJ; Orr, MS; Rodriguez-Galindo, C; Yang, C; Yang, H | 1 |
Bibeau, F; Cebotaru, C; El Weshi, A; Fadel, C; Fenaux, P; Frayfer, J; Laribi, K; Ribrag, V | 1 |
Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Palangie, T; Parrot, R; Poisson, M; Pouillart, P | 1 |
Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P | 1 |
Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Nielsen, D | 1 |
Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Rasmussen, D | 1 |
Carpenter, JT; Cox, EB; Raney, M; Vogel, CL | 1 |
7 review(s) available for arginine and Breast Cancer
Article | Year |
---|---|
Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer.
Topics: Animals; Arginine; Arthritis, Rheumatoid; Autoimmune Diseases; Breast Neoplasms; Cell Proliferation; Chromatin; Citrullination; Disease Progression; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunity; Multiple Sclerosis; Protein-Arginine Deiminase Type 2; RNA Polymerase II; Substrate Specificity | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies.
Topics: Animals; Arginine; Breast Neoplasms; Epigenesis, Genetic; Female; Humans; Methylation | 2019 |
Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antioxidants; Arginine; Breast Neoplasms; Fluorouracil; Humans; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species | 2019 |
Nonessential amino acid metabolism in breast cancer.
Topics: Animals; Arginine; Breast Neoplasms; Cysteine; Diet Therapy; Female; Food Deprivation; Glutamic Acid; Glutamine; Glycine; Humans; Metabolic Networks and Pathways; Proline; Serine | 2016 |
Protein arginine methylation in estrogen signaling and estrogen-related cancers.
Topics: Animals; Arginine; Breast Neoplasms; Estrogens; Female; Humans; Male; Methylation; Models, Biological; Neoplasms; Protein-Arginine N-Methyltransferases; Receptors, Estrogen; Signal Transduction | 2010 |
Nitric oxide, N omega-hydroxy-L-arginine and breast cancer.
Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Female; Humans; Nitric Oxide | 2008 |
10 trial(s) available for arginine and Breast Cancer
Article | Year |
---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Topics: Adipose Tissue, White; Adult; Aged; Air Pollutants; Animals; Anti-Inflammatory Agents; Arginine; bcl-2-Associated X Protein; Biofuels; Biological Products; Blood Glucose; Breast Neoplasms; Caspases; CD36 Antigens; Cell Communication; Cell Proliferation; Cell Survival; Cooking; Cross-Sectional Studies; Databases, Factual; Diabetes Mellitus, Type 2; Diphtheria Toxin; Double-Blind Method; Exenatide; Extracellular Polymeric Substance Matrix; Feasibility Studies; Female; Filgrastim; Fruit; Galactose; Gene Deletion; Gene Knockdown Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Glycated Hemoglobin; Hematopoietic Stem Cell Mobilization; Household Articles; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Lung; Lymphoma; Male; Metals, Heavy; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nanoparticles; Neoplasms; Obesity; Obstetrics; Odds Ratio; Oxygen; Peripheral Blood Stem Cell Transplantation; Photochemotherapy; Plant Extracts; Polyethylene Glycols; Polyglutamic Acid; Porosity; Postprandial Period; Prospective Studies; Quality of Life; Receptors, Glucagon; Receptors, LDL; Receptors, Somatostatin; Registries; Rhodophyta; Rhodotorula; Risk Factors; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction; Somatostatin; Stilbenes; Terminalia; Treatment Outcome; United States; Venoms | 2021 |
FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Base Sequence; Breast Neoplasms; Chemotherapy, Adjuvant; DNA Primers; Female; Genotype; Humans; Immunohistochemistry; Middle Aged; Prognosis; Receptor, Fibroblast Growth Factor, Type 4; Remission Induction | 2010 |
Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Middle Aged; Prednisone; Vincristine | 1994 |
Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Humans; Mammography; Mastectomy; Middle Aged; Neoplasm Staging; Prednisone; Radiotherapy Dosage; Ultrasonography; Vincristine | 1994 |
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine | 1998 |
Stimulation of human breast cancers by dietary L-arginine.
Topics: Administration, Oral; Arginine; Breast Neoplasms; Female; Humans; Ki-67 Antigen; Mitosis; Neoplasm Proteins; Nuclear Proteins; Stimulation, Chemical | 1992 |
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Norethindrone; Tamoxifen; Teniposide; Vincristine | 1984 |
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Glioma; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1977 |
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy.
Topics: Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Teniposide | 1992 |
157 other study(ies) available for arginine and Breast Cancer
Article | Year |
---|---|
Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
Topics: Animals; Arginine; Aspartic Acid; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glycine; Heterografts; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Polyesters | 2022 |
An integrated metabonomics study to reveal the inhibitory effect and metabolism regulation of taurine on breast cancer.
Topics: Animals; Arginine; Breast Neoplasms; Choline; Female; Glutamic Acid; Histidine; Humans; Isoleucine; Lactic Acid; Leucine; Lung Neoplasms; Metabolomics; Mice; Taurine; Valine | 2022 |
Combination of Electrochemistry and Mass Spectrometry to Study Nitric Oxide Metabolism and Its Modulation by Compound K in Breast Cancer Cells.
Topics: Arginine; Breast Neoplasms; Electrochemistry; Female; Ginsenosides; Humans; Metal Nanoparticles; Nitric Oxide; Pharmaceutical Preparations; Platinum; Tandem Mass Spectrometry | 2022 |
Investigation of the Lethal Effect of Purified Arginine Deiminase Purified from Lactobacillus plantarum p5 on Murine Mammary Adenocarcinoma and Vero cell Lines.
Topics: Adenocarcinoma; Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; Hydrolases; Lactobacillus plantarum; Mammary Neoplasms, Animal; Mice; Vero Cells | 2022 |
LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells.
Topics: Animals; Arginine; Argininosuccinate Synthase; Breast; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Epithelial Cells; Female; Humans; Interferon-gamma; Leucyl Aminopeptidase | 2022 |
L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
Topics: Apoptosis; Arginase; Arginine; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; G1 Phase; Humans | 2023 |
Anti-cancer effect of Rumex obtusifolius in combination with arginase/nitric oxide synthase inhibitors via downregulation of oxidative stress, inflammation, and polyamine synthesis.
Topics: Animals; Antioxidants; Arginase; Arginine; Breast Neoplasms; Down-Regulation; Female; Humans; Inflammation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Polyamines; Rats; Rumex | 2023 |
Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors.
Topics: Arginine; Breast Neoplasms; Chromatography, Liquid; Female; Humans; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Proteome; Repressor Proteins; Tandem Mass Spectrometry | 2023 |
Common alterations in plasma free amino acid profiles and gut microbiota-derived tryptophan metabolites of five types of cancer patients.
Topics: Amino Acids; Arginine; Breast Neoplasms; Female; Gastrointestinal Microbiome; Humans; Tryptophan; Tumor Microenvironment | 2023 |
PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer.
Topics: Arginine; Breast Neoplasms; Female; Humans; Methylation; Nuclear Proteins; Protein-Arginine N-Methyltransferases; STAT3 Transcription Factor | 2023 |
Topics: Animals; Apoptosis; Arginine; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Neuropeptide Y; Tissue Distribution; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
The potential therapeutic effect of N
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Arginase; Arginine; Breast Neoplasms; Female; Mortality; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Polyamines; Rats, Wistar | 2019 |
A Supramolecular Stabilizer of the 14-3-3ζ/ERα Protein-Protein Interaction with a Synergistic Mode of Action.
Topics: 14-3-3 Proteins; Amino Acid Motifs; Amino Acid Sequence; Arginine; Breast Neoplasms; Estrogen Receptor alpha; Glycosides; Humans; Molecular Dynamics Simulation; Peptides; Protein Binding | 2020 |
The effect of opine on matrix metalloproteinase expression in mice with breast cancer.
Topics: Animals; Arginine; Breast Neoplasms; Female; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred BALB C | 2022 |
Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.
Topics: Arginine; Breast Neoplasms; Cell Line, Tumor; Histone Demethylases; Humans; Methylation; Protein Processing, Post-Translational; Ubiquitin-Specific Peptidase 7 | 2020 |
C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.
Topics: Animals; Arginine; Benzhydryl Compounds; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Complement C3; Cytokines; Extracellular Matrix Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Complement; Signal Transduction | 2020 |
PRMT6-mediated H3R2me2a guides Aurora B to chromosome arms for proper chromosome segregation.
Topics: Amino Acid Sequence; Arginine; Aurora Kinase B; Breast Neoplasms; Centromere; Chromosomal Proteins, Non-Histone; Chromosome Segregation; Chromosomes, Human; Cytokinesis; Demethylation; Disease Progression; Female; HeLa Cells; Histones; Humans; MCF-7 Cells; Methylation; Mitosis; Nuclear Proteins; Phosphorylation; Protein-Arginine N-Methyltransferases; RNA, Small Interfering | 2020 |
Correction of arginine metabolism with sepiapterin-the precursor of nitric oxide synthase cofactor BH
Topics: Arginine; B7-H1 Antigen; Biopterins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Macrophages; Nitric Oxide; Nitric Oxide Synthase; Polyamines; Pterins; STAT3 Transcription Factor; THP-1 Cells | 2020 |
Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation.
Topics: Animals; Arginine; Breast Neoplasms; Citrullination; Citrulline; Female; Glycosylation; Histones; Humans; MCF-7 Cells; Methylation; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Nucleosomes; Protein-Arginine Deiminase Type 4; Pyruvaldehyde | 2020 |
Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling.
Topics: Animals; Arginine; Breast; Breast Neoplasms; Cell Line, Tumor; Endosomes; Female; Focal Adhesion Kinase 1; Humans; Methylation; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Protein-Arginine N-Methyltransferases | 2020 |
Pharmacologic downregulation of protein arginine methyltransferase1 expression by adenosine dialdehyde increases cell senescence in breast cancer.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Betaine-Homocysteine S-Methyltransferase; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methylation; Molecular Docking Simulation; Oxidative Stress; Phosphatidylethanolamine N-Methyltransferase; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Signal Transduction; Tamoxifen | 2021 |
Gene-Environment Interaction between Arg72Pro SNP and Selected Environmental Exposures among Brazilian Women Diagnosed with Benign Breast Disease.
Topics: Arginine; Brazil; Breast Neoplasms; Cross-Sectional Studies; Environmental Exposure; Female; Follow-Up Studies; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Tumor Suppressor Protein p53 | 2020 |
Indicators of L-arginine metabolism in saliva: A focus on breast cancer.
Topics: Arginase; Arginine; Breast Neoplasms; Case-Control Studies; Humans; Saliva | 2021 |
RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation.
Topics: Animals; Arginine; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Disease Progression; Female; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Kinetics; Lysine; Mechanistic Target of Rapamycin Complex 1; Mice, Nude; Phosphorylation; Proteolysis; Proto-Oncogene Proteins c-akt; Ubiquitin-Protein Ligases; Ubiquitination | 2021 |
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
Topics: Alternative Splicing; Amino Acid Sequence; Arginine; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Heterogeneous Nuclear Ribonucleoprotein A1; Humans; Male; Methylation; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; RNA, Small Interfering; Spliceosomes; Substrate Specificity | 2021 |
Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS.
Topics: Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Lysine; Methylation; Mitochondria; Neoplasm Metastasis; Organoids; Oxidative Phosphorylation; Protein Methyltransferases; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases | 2021 |
The comparison of Zn(II) arginine dithiocarbamate cytotoxicity in T47D breast cancer and fibroblast cells.
Topics: Antineoplastic Agents; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Congresses as Topic; Female; Fibroblasts; Humans; Thiocarbamates; Zinc | 2021 |
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.
Topics: Animals; Antineoplastic Agents; Arginine; Biocatalysis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Enzyme Activation; Female; HEK293 Cells; Humans; Methylation; Mice, Nude; Mutation; Protein Binding; Protein Kinase Inhibitors; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Small Interfering; Signal Transduction | 2021 |
siRNA-loaded poly(histidine-arginine)
Topics: Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Chitosan; Endosomes; Female; Histidine; Humans; Mice, Inbred BALB C; Nanoparticles; RNA, Small Interfering; Transfection; Xenograft Model Antitumor Assays | 2017 |
Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition.
Topics: Amino Acid Motifs; Antineoplastic Agents; Arginine; Breast Neoplasms; Chromatography, High Pressure Liquid; Computational Biology; Enzyme Inhibitors; Female; Gene Knockout Techniques; HEK293 Cells; Humans; MCF-7 Cells; Methylation; Molecular Targeted Therapy; Mutation; Proline; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Substrate Specificity; Tandem Mass Spectrometry | 2017 |
The Horizon in Cardio-Oncology: "You Are Only as Good as Your Endothelium".
Topics: Arginine; Breast Neoplasms; Endothelium; Heart Diseases; Humans; Neoplasms; Nitric Oxide | 2017 |
Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Arginine; Biomarkers, Tumor; Breast Neoplasms; Cardiomyopathies; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Nitric Oxide; Oxidative Stress; Prospective Studies; Time Factors; Trastuzumab | 2017 |
Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.
Topics: Adult; Arginine; Breast Neoplasms; Citrulline; Female; Genetic Predisposition to Disease; Glutamine; Humans; Mastectomy; Metabolic Clearance Rate; Middle Aged; Nitric Oxide; Postoperative Complications; Postprandial Period | 2018 |
Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.
Topics: Arginine; Breast Neoplasms; Carcinogenesis; Cell Proliferation; ErbB Receptors; Female; Histidine; Humans; Hydrogen-Ion Concentration; Mutation; Protein Conformation; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2017 |
Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction.
Topics: Arginine; Breast Neoplasms; Heart Diseases; Humans; Nitric Oxide | 2017 |
Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity.
Topics: Anthracyclines; Arginine; Brachial Artery; Breast Neoplasms; Cardiotoxicity; Dilatation; Early Detection of Cancer; Heart Diseases; Humans; Nitric Oxide | 2017 |
Reply: Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction.
Topics: Arginine; Breast Neoplasms; Heart Diseases; Humans; Nitric Oxide | 2017 |
A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.
Topics: Animals; Apoptosis; Arginine; Binding Sites; Breast Neoplasms; Cell Movement; Cell Proliferation; Chitinase-3-Like Protein 1; Female; Heparin; Humans; Lysine; Mice; Mice, SCID; Mutation; Neovascularization, Pathologic; Protein Binding; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-κB-GCN2/eIF2α signaling pathway in mammary epithelial cells in vitro and in vivo.
Topics: Animals; Arginine; Breast; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial Cells; Eukaryotic Initiation Factor-2; Female; Humans; Interferon-gamma; Mice; NF-kappa B; Protein Serine-Threonine Kinases; Protein Transport; Signal Transduction | 2018 |
Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells.
Topics: Arginine; Breast Neoplasms; Cell Line, Tumor; Estrogens; Female; Humans; MCF-7 Cells; Receptors, Estrogen | 2018 |
L-arginine/5-fluorouracil combination treatment approaches cells selectively: Rescuing endothelial cells while killing MDA-MB-468 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Fluorouracil; Glycolysis; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Docking Simulation; Nitric Oxide; Vascular Endothelial Growth Factor A | 2019 |
Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription.
Topics: Arginine; Breast Neoplasms; Cell Proliferation; Citrullination; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Positive Transcriptional Elongation Factor B; Promoter Regions, Genetic; Protein Binding; Protein Domains; Protein Processing, Post-Translational; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminases; RNA Polymerase II; Signal Transduction; Transcription, Genetic | 2019 |
Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
Topics: Animals; Arginase; Arginine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Models, Animal; Energy Metabolism; Female; Humans; Lipid Metabolism; Lipids; Metabolomics; Mice; Mice, Inbred BALB C; Neoplasm Staging; Polyamines; Tandem Mass Spectrometry | 2018 |
Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.
Topics: Antibiotics, Antineoplastic; Arginine; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Compounding; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Humans; MCF-7 Cells; Molecular Structure; Polyethyleneimine; RNA, Small Interfering | 2019 |
Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Topics: Animals; Arginine; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Deacetylases; Humans; Methylation; Mice, Inbred BALB C; Protein-Arginine N-Methyltransferases; Repressor Proteins; Xenograft Model Antitumor Assays | 2019 |
PELP1 oncogenic functions involve CARM1 regulation.
Topics: Animals; Arginine; Breast Neoplasms; Chromatin Immunoprecipitation; Co-Repressor Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; MCF-7 Cells; Methylation; Mice; Promoter Regions, Genetic; Protein Interaction Mapping; Protein-Arginine N-Methyltransferases; Proto-Oncogene Mas; Proto-Oncogene Proteins; RNA, Small Interfering; Transcription Factors; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2013 |
High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.
Topics: Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Profiling; Gene Silencing; Heat-Shock Proteins; Humans; Kinetics; Mammary Neoplasms, Experimental; Mice; MicroRNAs; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Polyethyleneimine; RNA, Small Interfering; Silicon; STAT3 Transcription Factor | 2013 |
Proteomic identification of mitochondrial targets of arginase in human breast cancer.
Topics: Animals; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Electrophoresis, Gel, Two-Dimensional; Female; Glycine Hydroxymethyltransferase; Humans; Mass Spectrometry; Mice; Mice, Nude; Middle Aged; Mitochondria; Mitochondrial Proteins; Proteomics; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Tumor Burden | 2013 |
JMJD6 regulates ERα methylation on arginine.
Topics: Arginine; Blotting, Western; Breast Neoplasms; Chromatography, Affinity; DNA Methylation; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Immunoprecipitation; Jumonji Domain-Containing Histone Demethylases; Protein Processing, Post-Translational; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2014 |
Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Arginine; Argininosuccinate Synthase; Autophagy; Breast Neoplasms; Cell Line, Tumor; Disease-Free Survival; Female; Humans; Hydrolases; Interleukin Receptor Common gamma Subunit; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Polyethylene Glycols; Prognosis; Xenograft Model Antitumor Assays | 2014 |
Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms.
Topics: Amino Acid Motifs; Amino Acid Sequence; Arginine; Binding, Competitive; Breast Neoplasms; Cell Nucleus; Cell Proliferation; Estrogen Receptor alpha; Female; Gene Silencing; HSP90 Heat-Shock Proteins; Humans; Ligands; MCF-7 Cells; Methylation; Molecular Sequence Data; Nuclear Proteins; Protein Binding; Protein-Arginine N-Methyltransferases; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; src-Family Kinases; Up-Regulation | 2014 |
The therapy of gefitinib towards breast cancer partially through reversing breast cancer biomarker arginine.
Topics: Adult; Antineoplastic Agents; Area Under Curve; Arginine; Breast Neoplasms; Case-Control Studies; Female; Gefitinib; Humans; Mass Spectrometry; Metabolomics; Predictive Value of Tests; Quinazolines; ROC Curve; Sensitivity and Specificity | 2015 |
Argininosuccinate lyase is a potential therapeutic target in breast cancer.
Topics: Arginine; Argininosuccinate Lyase; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin A2; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Humans; Nitric Oxide; RNA, Small Interfering | 2015 |
Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis.
Topics: Amino Acid Motifs; Arginine; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; DNA Damage; Female; Gene Expression Regulation, Neoplastic; Genomic Instability; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Methylation; Protein-Arginine N-Methyltransferases; Ubiquitination | 2015 |
Free DOX and chitosan-N-arginine conjugate stabilized indocyanine green nanoparticles for combined chemophotothermal therapy.
Topics: Antibiotics, Antineoplastic; Arginine; Breast Neoplasms; Chitosan; Combined Modality Therapy; Doxorubicin; Humans; Hyperthermia, Induced; Indocyanine Green; MCF-7 Cells; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Phototherapy | 2015 |
[Association of the Arg399Gln polymorphisms of the XRCC1 gene with breast cancer risk in Kyrgiz women].
Topics: Adult; Aged; Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; DNA, Neoplasm; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Heterozygote; Humans; Kyrgyzstan; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Assessment; Risk Factors; X-ray Repair Cross Complementing Protein 1 | 2015 |
An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy.
Topics: Arginine; Autophagy; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Interleukin-2; Interleukin-4; Interleukin-6; MCF-7 Cells; Molecular Weight; Nuclear Proteins; Protein Processing, Post-Translational; Sirolimus; Tumor Microenvironment; Uterine Cervical Neoplasms | 2016 |
A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Topics: A549 Cells; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma of Lung; Arginine; Breast Neoplasms; Carcinoma, Squamous Cell; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Lung Neoplasms; MCF-7 Cells; Methylation; Neoplasm Invasiveness; Neoplasms; Prognosis; Protein-Arginine N-Methyltransferases; Sequence Analysis, RNA; Transcription, Genetic; Transforming Growth Factor beta | 2017 |
N
Topics: Arginine; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; MCF-7 Cells; Receptors, Estrogen | 2016 |
A nanobiosensor for the detection of arginase activity.
Topics: Animals; Arginase; Arginine; Biosensing Techniques; Breast Neoplasms; Metal Nanoparticles; Mice, Inbred BALB C; Nitric Oxide; Ornithine | 2017 |
Identification of arginine and its "Downstream" molecules as potential markers of breast cancer.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Female; Humans; Middle Aged; Ornithine; ROC Curve; Spermine; Young Adult | 2016 |
Association of plasma arginine with breast cancer molecular subtypes in women of Liaoning province.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Arginine; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; China; Female; Humans; Middle Aged; ROC Curve | 2016 |
l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis.
Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Movement; Cell Survival; Chemokine CXCL12; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Humans; Lactic Acid; MCF-7 Cells; Models, Biological; Neoplasm Invasiveness; Nitric Oxide; Receptors, CXCR4; RNA, Messenger | 2017 |
Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells.
Topics: 3-Mercaptopropionic Acid; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dipeptides; Estradiol; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Nitric Oxide; Prolactin; Protease Inhibitors; Proteins; RNA, Messenger; Transfection; Up-Regulation | 2008 |
Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer.
Topics: Adult; Aged; Alleles; Arginine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Codon; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Hypoxia; Kaplan-Meier Estimate; Middle Aged; Neoplasm Proteins; Polymorphism, Single Nucleotide; Proline; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2008 |
Regulation of estrogen rapid signaling through arginine methylation by PRMT1.
Topics: Animals; Arginine; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytoplasm; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogens; Genome, Human; Humans; Methylation; Mice; Models, Biological; NIH 3T3 Cells; Phosphatidylinositol 3-Kinases; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins pp60(c-src); Receptor Cross-Talk; Repressor Proteins; Signal Transduction; Substrate Specificity | 2008 |
Structural basis for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Arginine; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coenzymes; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Mutant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substrate Specificity | 2009 |
Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.
Topics: Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glutamine; Humans; Nigeria; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Postmenopause; Premenopause; Receptors, Leptin; Risk Factors; Signal Transduction | 2008 |
Influence of protoporphyrin IX amino acid substituents on affinity to human breast adenocarcinoma MCF-7 cells.
Topics: Amino Acids, Diamino; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Histocytochemistry; Humans; Microscopy, Fluorescence; Protoporphyrins | 2009 |
Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin.
Topics: Alternative Splicing; Amino Acid Substitution; Arginine; BRCA1 Protein; Breast Neoplasms; DNA Mutational Analysis; Genotype; Glycine; Haplotypes; Humans; Polymorphism, Single Nucleotide; Portugal; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |
The polymorphism of DNA repair gene ERCC2/XPD Arg156Arg and susceptibility to breast cancer in a Chinese population.
Topics: Adult; Age of Onset; Alleles; Arginine; Asian People; Breast Neoplasms; Case-Control Studies; DNA Repair; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Xeroderma Pigmentosum Group D Protein | 2009 |
Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
Topics: Amino Acid Substitution; Animals; Arginine; Aromatase Inhibitors; Breast Neoplasms; CHO Cells; Cricetinae; Cricetulus; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Humans; Lysine; Mice; Mice, Nude; Mutation, Missense; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Prognosis; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
Topics: Arginine; Breast Neoplasms; Cadherins; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclin A; Down-Regulation; Epithelial Cells; ErbB Receptors; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Dominant; Genes, erbB-1; Histidine; Humans; Immunoblotting; Laser Scanning Cytometry; Matrix Metalloproteinase 9; Mutation; Phosphorylation; Retroviridae; RNA, Small Interfering; Transcriptional Activation; Transduction, Genetic; Tumor Suppressor Protein p53 | 2009 |
TP53 mutations and Arg72Pro polymorphism in breast cancers.
Topics: Amino Acid Substitution; Arginine; Breast Neoplasms; Case-Control Studies; Codon; Genotype; Humans; Lymphatic Metastasis; Mutation; Polymorphism, Single Nucleotide; Proline; Tumor Suppressor Protein p53 | 2009 |
TP53 codon 72 polymorphism and breast cancer in northern Iran.
Topics: Adult; Arginine; Breast Neoplasms; Codon; Female; Gene Frequency; Genes, p53; Genotype; Heterozygote; Homozygote; Humans; Iran; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Proline; Risk Factors | 2009 |
The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.
Topics: 3-Hydroxybutyric Acid; Animals; Arginine; Autophagy; Biomarkers; Breast Neoplasms; Caveolin 1; Female; Gene Expression Profiling; Humans; Mice; MicroRNAs; Models, Biological; Oxidative Stress; Stromal Cells | 2010 |
CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines.
Topics: Apoptosis; Arginine; Biological Transport; Blotting, Western; Breast Neoplasms; Cationic Amino Acid Transporter 1; Cationic Amino Acid Transporter 2; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cytoplasm; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Microscopy, Confocal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prolactin; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2011 |
A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Arginine; Breast Neoplasms; Cell Line, Tumor; ErbB Receptors; Female; Histidine; Humans; Mice; Mice, Nude; Mutation; Peptides; Recombinant Fusion Proteins; Xenograft Model Antitumor Assays | 2011 |
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine.
Topics: Arginine; Breast; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Eflornithine; Female; Humans | 2012 |
Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.
Topics: Alleles; Arginine; Breast Neoplasms; Case-Control Studies; Codon; Disease Progression; Female; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; India; Introns; Middle Aged; Neoplasm Staging; Obesity; Polymorphism, Genetic; Tumor Suppressor Protein p53 | 2011 |
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
Topics: Animals; Antithrombins; Arginine; Body Weight; Bone Neoplasms; Breast Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Mice; Pipecolic Acids; Sulfonamides; Thrombin; Thromboplastin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2013 |
Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Breast Neoplasms; Cell Line, Tumor; DNA; Female; Glutathione; Humans; Interleukin-12; Mice; Micelles; Paclitaxel; Particle Size; Polyamines; Polyethylene Glycols; Transfection | 2012 |
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
Topics: Animals; Arginine; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neuropeptide Y; Receptors, Estrogen; Receptors, Neuropeptide Y; Tamoxifen | 2012 |
Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithine.
Topics: Apoptosis; Arginine; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Cytochrome c Group; Female; Humans; Intracellular Membranes; Kinetics; Membrane Potentials; Mitochondria; Tumor Cells, Cultured | 2002 |
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
Topics: Alleles; Arginine; Base Sequence; Biopsy, Needle; Breast Neoplasms; Codon; Cohort Studies; Colorectal Neoplasms; DNA Mutational Analysis; Female; Genes, p53; Humans; Incidence; Loss of Heterozygosity; Male; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Prospective Studies; Risk Factors; Sensitivity and Specificity | 2002 |
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Arginine; Breast Neoplasms; Cell Line, Tumor; Codon; Disease-Free Survival; DNA; Female; Genes, p53; Genotype; Heterozygote; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Nucleic Acid Hybridization; Polymorphism, Genetic; Prognosis; Proline; Time Factors | 2003 |
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
Topics: Adenine; Adult; Aged; Arginine; Breast Neoplasms; Carcinoma, Ductal; Case-Control Studies; Codon; Cytosine; DNA Primers; DNA-Binding Proteins; Exons; Female; Genes, Tumor Suppressor; Genotype; Guanine; Homozygote; Humans; Logistic Models; Middle Aged; Nuclear Proteins; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Thymine; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2003 |
Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells.
Topics: Arginine; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Female; Humans; Mitosis; Nitric Oxide; omega-N-Methylarginine; Phosphorylation; Retinoblastoma Protein; Serine; Tumor Suppressor Protein p53 | 2004 |
Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.
Topics: Amino Acid Substitution; Arginine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Humans; Mutation, Missense; Neoplasm Proteins; Protein Binding; Rhodamine 123; Threonine | 2004 |
Tumour cell growth in culture: dependence on arginine.
Topics: Arginase; Arginine; Breast Neoplasms; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Female; Humans; Leucine; Nitric Oxide; Protein Biosynthesis; Proteins; Signal Transduction | 2004 |
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Topics: Adult; Aged; Arginine; Breast Neoplasms; Case-Control Studies; Codon; DNA Mutational Analysis; Female; Genes, p53; Genetic Predisposition to Disease; Humans; Japan; Menopause; Middle Aged; Polymorphism, Genetic; Proline; Receptors, Estrogen; Risk Factors | 2004 |
Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2).
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile Acids and Salts; Biological Transport; Breast Neoplasms; Estradiol; Gene Expression Regulation; Glycine; Humans; Lactococcus lactis; Methotrexate; Mutation, Missense; Neoplasm Proteins; Rhodamine 123; Sterols | 2005 |
Modulation of cathepsin D routing by IGF-II involves IGF-II binding to IGF-II/M6P receptor in MCF-7 breast cancer cells.
Topics: Animals; Arginine; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cathepsin D; Cell Line; Cell Line, Tumor; Culture Media, Conditioned; DNA, Complementary; Dose-Response Relationship, Drug; Genetic Vectors; Humans; Immunoblotting; Immunoprecipitation; Insulin-Like Growth Factor II; Lysosomes; Mice; Microsomes, Liver; Radioimmunoassay; RNA, Messenger; Time Factors; Transfection | 2004 |
Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress.
Topics: Arginine; Breast Neoplasms; Female; Humans; Hydrogen Peroxide; Oxidants; Oxidative Stress; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Tumor Cells, Cultured; Ubiquitins | 2005 |
Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?
Topics: Adult; Aged; Arginine; Breast Neoplasms; Case-Control Studies; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Neoplasms; Pancreatic Neoplasms; Weight Loss | 2005 |
Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.
Topics: Alanine; Arginine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Separation; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Genes, Tumor Suppressor; Glutathione; Glutathione Transferase; HeLa Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Immunoprecipitation; Male; Microscopy, Fluorescence; Neoplasm Metastasis; Oxidative Stress; Plasmids; Point Mutation; Prostatic Neoplasms; Protein Binding; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Transfection; Two-Hybrid System Techniques | 2005 |
FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.
Topics: Alleles; Amino Acid Substitution; Arginine; Breast Neoplasms; Cell Line; Cell Movement; Cells, Cultured; Disease Progression; Down-Regulation; Female; Gene Expression Regulation; Glycine; Humans; Polymorphism, Single Nucleotide; Protein Isoforms; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Lysophosphatidic Acid; Signal Transduction | 2006 |
Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis.
Topics: Adult; Alanine; Amino Acid Substitution; Arginine; Asian People; Breast Neoplasms; Case-Control Studies; China; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Middle Aged; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polymorphism, Genetic; Risk; Valine; X-ray Repair Cross Complementing Protein 1 | 2006 |
Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
Topics: Arginine; Body Mass Index; Breast Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Linkage Disequilibrium; Middle Aged; Polymorphism, Genetic; Proline; Proportional Hazards Models; Radiodermatitis; Radiotherapy; Retrospective Studies; Serine; Tumor Suppressor Protein p53 | 2006 |
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Topics: Adenoviridae; Alanine; Animals; Arginine; Blotting, Western; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA-Binding Proteins; DNA, Complementary; Female; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Glycine; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutagenesis, Insertional; Neoplasm Invasiveness; Polymerase Chain Reaction; Proline; Proto-Oncogene Proteins; Repressor Proteins; Signal Transduction; Smad6 Protein; Smad7 Protein; Transforming Growth Factor beta; Up-Regulation | 2005 |
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
Topics: Adenocarcinoma; Arginine; Breast Neoplasms; Humans; Hydrolases; Lung Neoplasms; Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Polyamines; Protein Biosynthesis; Tumor Cells, Cultured | 2006 |
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Arginine; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Drug Resistance, Neoplasm; Female; Genetic Markers; Genotype; Glycine; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Mutation, Missense; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptor, Fibroblast Growth Factor, Type 4 | 2006 |
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.
Topics: Animals; Arginine; Breast Neoplasms; Cell Adhesion; Cell Growth Processes; Green Fluorescent Proteins; HT29 Cells; Humans; Leucine; Mice; Mice, Nude; Neoplasm Invasiveness; Salmonella typhimurium; Transfection; Xenograft Model Antitumor Assays | 2006 |
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
Topics: Amino Acid Sequence; Apoptosis; Arginine; Binding Sites; Breast Neoplasms; Carcinoma; Cells, Cultured; Codon; Conserved Sequence; Female; Gene Expression Regulation; Homozygote; Humans; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Polymorphism, Genetic; Proline; Repressor Proteins; Tumor Suppressor Protein p53; Tyrosine | 2006 |
Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Arginine; Brazil; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Risk Factors | 2006 |
hCAF1, a new regulator of PRMT1-dependent arginine methylation.
Topics: Adaptor Proteins, Signal Transducing; Arginine; Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Female; Gene Expression Regulation; HeLa Cells; Histones; Humans; Methylation; Protein-Arginine N-Methyltransferases; Recombinant Fusion Proteins; RNA-Binding Proteins; RNA, Small Interfering; Transcription Factors | 2007 |
The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia.
Topics: Alleles; Apoptosis; Arginine; Breast Neoplasms; Cell Hypoxia; Codon; Female; Genes, p53; Humans; Proline | 2007 |
Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Eye Enucleation; Eye Neoplasms; Female; Humans; Hydrolases; Recombinant Proteins; Retinoblastoma | 2007 |
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Topics: Alanine; Arginine; Biomarkers, Tumor; Breast Neoplasms; Centrosome; DNA, Complementary; Factor Analysis, Statistical; Female; Genes, BRCA1; Genetic Predisposition to Disease; Glutamic Acid; Glutamine; Glycine; Humans; Immunohistochemistry; Keratins; Mutation, Missense; Nucleic Acid Amplification Techniques; Plasmids; Polymorphism, Single Nucleotide; Predictive Value of Tests; Receptors, Estrogen; Risk Assessment; Risk Factors; Sequence Analysis, DNA; Valine | 2007 |
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Topics: Animals; Anticoagulants; Arginine; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Female; Humans; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Osteopontin; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptors, Thrombin; Sulfonamides; Thrombin | 2008 |
Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine.
Topics: Arginine; Breast Neoplasms; Bucladesine; Cell Division; Cell Survival; Cells, Cultured; Cyclic AMP; Drug Synergism; Female; Growth Inhibitors; Humans | 1981 |
The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
Topics: Aged; Arginine; Breast Neoplasms; Female; Growth Hormone; Humans; Menopause; Middle Aged; Prolactin; Tamoxifen | 1983 |
Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells.
Topics: Arginine; Breast Neoplasms; Cyclic GMP; Female; Humans; Nitric Oxide; Nitric Oxide Synthase; Relaxin; Thymidine; Tumor Cells, Cultured | 1995 |
The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.
Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Blotting, Southern; BRCA1 Protein; Breast Neoplasms; Cell Adhesion Molecules; Cell Line; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 17; Cosmids; Cricetinae; Cytoskeletal Proteins; Desmoplakins; DNA; DNA Primers; DNA, Neoplasm; Exons; Family; Female; gamma Catenin; Genetic Markers; Histidine; Humans; Hybrid Cells; Mice; Molecular Sequence Data; Neoplasm Proteins; Ovarian Neoplasms; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Transcription Factors | 1995 |
A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis.
Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Breast Neoplasms; Chickens; Codon; Conserved Sequence; DNA Primers; Exons; Female; Gene Amplification; Genes, p53; Haplorhini; Histidine; Humans; Mice; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Rats; Sequence Homology, Amino Acid; Trout; Tumor Suppressor Protein p53; Xenopus | 1994 |
L-arginine stimulates host defenses in patients with breast cancer.
Topics: Aged; Arginine; Breast Neoplasms; Cytokines; Cytotoxicity, Immunologic; Female; Humans; Immunization; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Subsets; Middle Aged; Mitogens; Phenotype | 1994 |
Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.
Topics: Arginine; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; Humans; Molecular Sequence Data; Oncogene Proteins; Point Mutation; Protein Binding; Structure-Activity Relationship; Tryptophan | 1996 |
ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production.
Topics: Arginine; Breast Neoplasms; Female; Humans; Immunoenzyme Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1998 |
(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors.
Topics: Amino Acid Sequence; Animals; Arginine; Breast Neoplasms; Cyclic AMP; Gene Expression; Genes, fos; Humans; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Receptors, Vasoactive Intestinal Peptide; RNA, Messenger; Structure-Activity Relationship; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1998 |
p53 polymorphism and risk of cervical cancer.
Topics: Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Humans; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Repressor Proteins; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1998 |
G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.
Topics: Amino Acid Substitution; Apoptosis; Arginine; Breast Neoplasms; Cell Cycle; Cell Division; Cell Nucleus; Cell Transformation, Neoplastic; DNA-Binding Proteins; Female; G1 Phase; Genes, Reporter; Genes, Tumor Suppressor; Humans; In Situ Nick-End Labeling; Kinetics; Mutagenesis, Site-Directed; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Smad4 Protein; Threonine; Trans-Activators; Transfection; Tumor Cells, Cultured | 1999 |
The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer.
Topics: Amino Acid Substitution; Arginine; Asparagine; Base Sequence; Breast; Breast Neoplasms; Cell Division; Estradiol; Exons; Female; Fibrocystic Breast Disease; Genetic Variation; Glycosylation; Humans; Point Mutation; Polymorphism, Restriction Fragment Length; Reference Values; Sex Hormone-Binding Globulin | 1999 |
Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Topics: Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Cycle; Cell Division; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Humans; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Reverse Transcriptase Polymerase Chain Reaction; Spermine; Tumor Cells, Cultured | 2000 |
p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
Topics: Adult; Alleles; Amino Acid Substitution; Arginine; Breast Neoplasms; Codon; Female; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Middle Aged; Neoplasm Staging; Polymorphism, Genetic; Proline; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53 | 2000 |
In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Caspase 3; Caspases; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Female; Glycine; Humans; Point Mutation; Prolactin; Transforming Growth Factor alpha; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured | 2001 |
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
Topics: Adult; Age of Onset; Alleles; Arginine; Arylsulfotransferase; Blotting, Northern; Breast Neoplasms; Case-Control Studies; Estrogens; Exons; Female; Genotype; Histidine; Humans; Immunoblotting; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 2000 |
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.
Topics: Adenocarcinoma; Animals; Arginase; Arginine; Biogenic Polyamines; Breast Neoplasms; Cell Division; Coculture Techniques; Cytotoxicity, Immunologic; Humans; Macrophage Activation; Macrophages; Mice; Nitric Oxide; Ornithine; Rats; Transfection; Valine | 2001 |
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene.
Topics: Amino Acid Sequence; Arginine; Aspartic Acid; Breast Neoplasms; Female; Glutamic Acid; Glycine; Humans; Lung Neoplasms; Melanoma; Molecular Sequence Data; Neoplasms; Peptide Fragments; Phosphoprotein Phosphatases; Point Mutation; Protein Binding; Protein Phosphatase 2; Protein Structure, Secondary; Tryptophan | 2001 |
Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
Topics: Arginine; bcl-2-Associated X Protein; Binding Sites; Breast Neoplasms; Codon; Consensus Sequence; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; Female; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Substrate Specificity; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines.
Topics: Adenosylmethionine Decarboxylase; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Activation; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Ornithine; Ornithine Decarboxylase; Polyamines; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2001 |
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Topics: Alleles; Amino Acid Sequence; Arginine; Breast Neoplasms; Cell Movement; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Genotype; Humans; Molecular Sequence Data; Mutation, Missense; Polymorphism, Single Nucleotide; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Tumor Cells, Cultured | 2002 |
Hormonal changes following hypophysectomy in humans.
Topics: Androstenedione; Arginine; Breast Neoplasms; Cold Temperature; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hypophysectomy; Luteinizing Hormone; Pituitary Hormones; Prolactin; Testosterone; Thyrotropin; Thyrotropin-Releasing Hormone | 1977 |
Mapping the cellular distribution of labelled molecules by SIMS microscopy.
Topics: Adenine; Adult; Arginine; Breast Neoplasms; Carbon Radioisotopes; Cells, Cultured; Deuterium; Female; Fibroblasts; Humans; Mass Spectrometry; Microscopy; Nitrogen Isotopes; Thymidine; Tumor Cells, Cultured | 1992 |
Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine; Amino Acids; Arginine; Breast Neoplasms; Carcinoma, Squamous Cell; Discriminant Analysis; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Male; Middle Aged; Sex Factors; Threonine | 1992 |
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinic Acid; Blood Platelets; Breast Neoplasms; Creatinine; Dipyridamole; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Plasmapheresis; Sulfinpyrazone; Tablets, Enteric-Coated; Time Factors | 1986 |
Letter: Growth hormone after transsphenoidal hypophysectomy.
Topics: Arginine; Breast Neoplasms; Female; Growth Hormone; Humans; Hypophysectomy; Methods; Neoplasm Metastasis; Radioimmunoassay; Sphenoid Bone | 1974 |
Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine.
Topics: Amines; Animals; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; Teniposide | 2013 |
Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Maximum Tolerated Dose; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Particle Size; Polyesters; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Solubility; Teniposide; Xenograft Model Antitumor Assays | 2016 |
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Topics: Antibiotics, Antineoplastic; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Clone Cells; Cyclin-Dependent Kinase Inhibitor p21; Doxorubicin; Drug Resistance, Neoplasm; Gamma Rays; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Telomerase; Teniposide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2005 |
Clinical trials in cancer medicine.
Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms | 1980 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed | 1981 |
Phase II study of VM 26 in extensively pretreated breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Teniposide | 1984 |
Primary lymphoblastic lymphoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Teniposide; Vincristine | 1982 |
Phase II study of VM-26 in adult malignancies.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide; Thrombocytopenia | 1980 |
Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26.
Topics: Breast Neoplasms; Cell Line; DNA; Down-Regulation; Gene Expression; Humans; Proto-Oncogene Proteins c-myc; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic | 1995 |
Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carrier Proteins; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Membrane Glycoproteins; RNA, Messenger; Teniposide; Tumor Cells, Cultured | 1994 |
Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.
Topics: Blotting, Southern; Breast Neoplasms; Cell Division; DNA Damage; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; RNA, Neoplasm; Teniposide; Tumor Cells, Cultured | 1993 |
The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Breast Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Female; Glioblastoma; Humans; Male; Melanoma; Middle Aged; Oligodendroglioma; Skin Neoplasms; Teniposide | 1997 |
Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cells.
Topics: Antineoplastic Agents, Phytogenic; Binding Sites; Breast Neoplasms; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; E2F Transcription Factors; Humans; Luciferases; Phosphorylation; Plasmids; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Signal Transduction; Teniposide; Transcription Factor DP1; Transcription Factors; Transfection; Tumor Cells, Cultured | 1997 |
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Topics: Amsacrine; Bleomycin; Breast Neoplasms; Cell Division; Cell Survival; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; DNA Topoisomerases, Type II; Etoposide; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Recombinant Proteins; Teniposide; Topoisomerase II Inhibitors; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1995 |
Anticancer drugs induce increased mitochondrial cytochrome c expression that precedes cell death.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 9; Caspases; Cell Adhesion; Cytochrome c Group; DNA Fragmentation; Electron Transport; Electron Transport Complex IV; Enzyme Activation; Humans; Intracellular Membranes; Membrane Potentials; Microscopy, Fluorescence; Mitochondria; Poly(ADP-ribose) Polymerases; Teniposide; Tumor Cells, Cultured; Up-Regulation | 2001 |
Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Death; DNA Damage; G1 Phase; Gene Expression; Gene Silencing; Humans; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Proto-Oncogene Proteins c-myc; Teniposide; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Primary breast lymphoma: a report of 20 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2001 |
[Effectiveness of VM 26, mitomycine C and methotrexate in advanced breast cancer refractory to a four drug combination (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Drug Resistance; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1979 |
Phase II study of teniposide in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1990 |
Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Resistance; Female; Humans; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1988 |